Class II — Zest Anchors LLC
| Recalling firm | Zest Anchors, LLC |
|---|---|
| Registered facility | View this company's 3 registered facilities → (openFDA recall records do not name a specific facility) |
| Classification | Class II |
| Status | Terminated |
| Reason | Zest Anchors, LLC is voluntarily recalling specific lots of LOCATOR® Implant Attachment Systems because it is currently provided with a label that indicates that the final torque applied to the abutment should be 30 N-cm. It was recently noted by Zest that in order to provide an optimal performance by increasing the factor of safety between the failure load of the abutment screw and the recommend |
| Product | LOCATOR® Implant Attachment System. The LOCATOR® Implant Attachment System is a universal hinge, resilient attachment for endosseous implants. The LOCATOR® Implant Attachment System is designed for use with overdentures or partial dentures, retained in whole or in part, by endosseous implants in the mandible or maxilla. FDA 510(k): K994257, K072878 |
| Quantity | 3,130 |
| Distribution | Distributed in Ohio and Switzerland. |
| Initiated | 2014-01-16 |
| Classified | 2014-02-06 |
| Terminated | 2014-05-15 |
| Recall number | Z-0935-2014 |
| Initiation | Voluntary: Firm initiated |
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Class II recall — Zest Anchors LLC (Z-0935-2014).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/67315/
Alerts for Zest Anchors, LLC
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.